How a lung cancer immunotherapy works in real-world patients

This is an observational study that follows patients with advanced lung cancer who are receiving atezolizumab as their first treatment. Researchers will collect information from your routine medical care — such as imaging scans, lab tests, and how you're doing — to understand how well this medication works and how safe it is when used in real-world clinical practice, rather than in a controlled research setting.

While this medication has been approved for certain patients with advanced lung cancer, doctors want to learn more about how it actually works outside of strict research trials. By studying real patients receiving this treatment in everyday hospitals and clinics, researchers can better understand treatment patterns, who benefits most, and any side effects that might occur in practice.